{"url_path":"/sec/snse/8-k/2026-06-10/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-10","source_url":"https://www.sec.gov/Archives/edgar/data/1829802/0001193125-26-265879-index.html","accession_number":"0001193125-26-265879","cik":"0001829802","ticker":"FTH","issuer_name":"Faeth Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1829802/0001193125-26-265879-index.html","primary_entity_key":"0001829802","primary_entity_name":"Sensei Biotherapeutics, Inc."},"word_count":124,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits\n\n(d) Exhibits\n\n \n\nExhibit\nNumber\n\n  \n\nExhibit Description\n\n 3.1\n  \n[Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company, effective June 10, 2026](d142513dex31.htm)\n\n10.1\n  \n[2026 Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement, Restricted Stock Unit Grant Notice and Restricted Stock Unit Grant Agreement thereunder](d142513dex101.htm)\n\n10.2\n  \n[2026 Employee Stock Purchase Plan](d142513dex102.htm)\n\n104\n  \nCover Page Interactive Data File (embedded with the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \nSensei Biotherapeutics, Inc.\n\nDate: June 10, 2026\n \n\n \n\n \n\n/s/ Christopher W. Gerry\n\n \n \n \n \n \n \nChristopher W. Gerry\n\n \n \n \n \n \n \nPresident and General Counsel"}